1. FAT1 cadherin is multiply phosphorylated on its ectodomain but phosphorylation is not catalysed by the four‐jointed homologue. Issue 18 (19th August 2014) Authors: Sadeqzadeh, Elham; de Bock, Charles E.; O'Donnell, Maureen R.; Timofeeva, Anna; Burns, Gordon F.; Thorne, Rick F. Journal: FEBS letters Issue: Volume 588:Issue 18(2014) Page Start: 3511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia. (1st November 2013) Authors: Ardjmand, Alireza; de Bock, Charles E.; Shahrokhi, Somayeh; Lincz, Lisa F.; Boyd, Andrew W.; Burns, Gordon F.; Thorne, Rick F. Journal: Hematology Issue: Volume 18:Number 6(2013) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia. (November 2013) Authors: Ardjmand, Alireza; de Bock, Charles E.; Shahrokhi, Somayeh; Lincz, Lisa F.; Boyd, Andrew W.; Burns, Gordon F.; Thorne, Rick F. Journal: Hematology Issue: Volume 18:Number 6(2013) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia. (4th May 2018) Authors: de Bock, Charles E.; Cools, Jan Journal: Molecular & cellular oncology Issue: Volume 5:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Malt1 self‐cleavage is critical for regulatory T cell homeostasis and anti‐tumor immunity in mice. Issue 10 (7th August 2018) Authors: Baens, Mathijs; Stirparo, Rocco; Lampi, Youlia; Verbeke, Delphine; Vandepoel, Roel; Cools, Jan; Marynen, Peter; de Bock, Charles E.; Bornschein, Simon Journal: European journal of immunology Issue: Volume 48:Issue 10(2018) Page Start: 1728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Protein interaction screening identifies SH3RF1 as a new regulator of FAT1 protein levels. Issue 4 (16th February 2017) Authors: de Bock, Charles E.; Hughes, Michael R.; Snyder, Kimberly; Alley, Steven; Sadeqzadeh, Elham; Dun, Matt D.; McNagny, Kelly M.; Molloy, Timothy J.; Hondermarck, Hubert; Thorne, Rick F. Journal: FEBS letters Issue: Volume 591:Issue 4(2017) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome. Issue 13 (9th November 2020) Authors: Laukkanen, Saara; Oksa, Laura; Nikkilä, Atte; Lahnalampi, Mari; Parikka, Mataleena; Seki, Masafumi; Takita, Junko; Degerman, Sofie; de Bock, Charles E.; Heinäniemi, Merja; Lohi, Olli Journal: Leukemia & lymphoma Issue: Volume 61:Issue 13(2020) Page Start: 3089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Promise of Single-cell Technology in Providing New Insights Into the Molecular Heterogeneity and Management of Acute Lymphoblastic Leukemia. Issue 6 (26th June 2022) Authors: Pearson, Holly C.L.; Hunt, Kooper V.; Trahair, Toby N.; Lock, Richard B.; Lee, Heather J.; de Bock, Charles E. Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗